Garvey Mary
Department of Life Science, Atlantic Technological University, F91 YW50 Sligo, Ireland.
Centre for Precision Engineering, Materials and Manufacturing Research (PEM), Atlantic Technological University, F91 YW50 Sligo, Ireland.
J Fungi (Basel). 2022 Nov 8;8(11):1179. doi: 10.3390/jof8111179.
Biologics have become an important area of medical research generating therapeutics essential for the treatment of many disease states. Biologics are defined as biologically active compounds manufactured by living cells or through biological processes termed bioprocessing. Compared to small molecules which are chemically synthesised they are relatively complex and therapeutically specific molecules. Biologics include hormones, vaccines, blood products, monoclonal antibodies, recombinant therapeutic proteins, enzymes, gene and cellular therapies amongst others. For biologic production prokaryotic and eukaryotic cells (mammalian and non-mammalian) are used as expression systems. Eukaryotic expression systems offer many advantages over prokaryotic based systems. The manufacture of high-quality proteins for human clinical use via recombinant technologies has been achieved in yeast and filamentous fungal systems. Advances in bioprocessing such as genetic engineering, bioreactor design, continuous processing, and quality by design has allowed for increased productivity and higher yield in in these non-mammalian eukaryotic systems with protein translation similar to mammalian systems. The application of eukaryotic expressions systems for the manufacture of biologics of therapeutic importance are described herein.
生物制品已成为医学研究的一个重要领域,产生了治疗许多疾病状态所必需的治疗药物。生物制品被定义为由活细胞制造或通过称为生物加工的生物过程产生的生物活性化合物。与化学合成的小分子相比,它们是相对复杂且治疗特异性的分子。生物制品包括激素、疫苗、血液制品、单克隆抗体、重组治疗蛋白、酶、基因和细胞疗法等。对于生物制品的生产,原核细胞和真核细胞(哺乳动物和非哺乳动物)被用作表达系统。真核表达系统比基于原核的系统具有许多优势。通过重组技术在酵母和丝状真菌系统中已实现了用于人类临床使用的高质量蛋白质的生产。生物加工方面的进展,如基因工程、生物反应器设计、连续加工和设计质量,已使这些非哺乳动物真核系统的生产率提高和产量增加,其蛋白质翻译与哺乳动物系统相似。本文描述了真核表达系统在制造具有治疗重要性的生物制品中的应用。